» Articles » PMID: 18472194

Efficient Augmentation of a Long-lasting Immune Responses in HIV-1 Gag DNA Vaccination by IL-15 Plasmid Boosting

Overview
Journal Vaccine
Date 2008 May 13
PMID 18472194
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokines are major regulators of the immune response, and have been used as adjuvants to improve vaccine potency. In this study, we investigated the adjuvant effects of interleukin (IL)-15 on improving the immunogenicity of human immunodeficiency virus (HIV)-1 gag DNA vaccine in Balb/c mice. During a 370-day follow-up, cellular and humoral immune responses in three separate cohorts of mice were monitored. These results were exemplified through: lymphocyte proliferation, induction of antigen-specific CD8(+) T lymphocytes, long-term production of specific antibodies, and proportion of differentiated memory CD8(+) T cells. These data revealed that just boost of IL-15 at day 8 after co-immunization induced more homeostatic cell proliferation, augmented proliferation frequency of IFN-gamma-secreting antigen-specific CD8(+) T lymphocytes, maintained the long-lasting humoral immune response and promoted the turnover of memory T cell precursors into central memory T cells. Taken together, our data demonstrated that a single IL-15 boosting can enhance both the humoral and cellular immune responses of the HIV-1 gag DNA vaccination. This novel boosting strategy may facilitate the application of IL-15 as an adjuvant for HIV vaccination.

Citing Articles

Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant.

Zhou Y, Zhang T, Wang Z, Xu X Virol J. 2025; 22(1):3.

PMID: 39780219 PMC: 11707914. DOI: 10.1186/s12985-024-02604-7.


Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Jones C, Hakansson A, Pfeifer B J Mater Chem B. 2018; 46:8053-8068.

PMID: 29887986 PMC: 5990286. DOI: 10.1039/C4TB01058B.


Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.

Garrod T, Grubor-Bauk B, Yu S, Gargett T, Gowans E Hum Vaccin Immunother. 2014; 10(9):2679-83.

PMID: 25483501 PMC: 4975063. DOI: 10.4161/hv.29527.


Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.

Wang R, Freywald A, Chen Y, Xu J, Tan X, Xiang J Cell Mol Immunol. 2014; 12(4):456-65.

PMID: 25195511 PMC: 4496542. DOI: 10.1038/cmi.2014.72.


Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.

Su L, Yu F, Li Z, Zeng C, Xu Q, Fan M Acta Pharmacol Sin. 2014; 35(5):592-8.

PMID: 24705100 PMC: 4814028. DOI: 10.1038/aps.2013.184.